What future research directions are needed?
During the first day-and-a-half of the conference, experts presented the latest ERCP research findings to an independent, non-Federal panel. The panel was composed of practicing clinicians, biomedical scientists, clinical study methodologists, and a public representative. After weighing all of the scientific evidence, the panel drafted a statement addressing the key questions listed above. The panel’s draft statement was presented to the conference audience on the final day of the conference. The lead sponsors for this conference were the National Institute of Diabetes and Digestive and Kidney Diseases and the NIH Office of Medical Applications of Research. Cosponsors included the National Cancer Institute and the U.S. Food and Drug Administration. The Agency for Healthcare Research and Quality (AHRQ) prepared the systematic review of the medical literature on ERCP through a contract with the BlueCross BlueShield Technology Evaluation Center Evidence-based Practice Center. 1. What is t
